Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05100862 |
|---|---|
| Brief Title: | A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (MAHOGANY) |
| First Submitted : | September 27, 2021 |
| First Submitted that Met QC Criteria : | October 21, 2021 |
| First Posted : | October 29, 2021 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |